Abstract
Material with a molecular weight of less than 10(5) daltons has been isolated and partially purified from the ascitic fluid of DBA2 mice bearing a syngeneic lymphoma (SL2). This substance inhibits the cytotoxic action of an allogeneic antiserum directed specifically against SL2 cells. Material has been rendered radioactive with 125I and between 20 and 25% of the radioactivity is bound in a specific manner to the antiserum. The material which is referred to as 125I-TSTA has been used in a radioimmunoassay to measure the level of TSTA in the sera of mice bearing both ascitic and subcutaneous SL2 tumours. The level of circulating TSTA was found to be high immediatley following inoculation of live SL2 cells, probably because a large proportion of the injected cells autolyse. The serum concentration of TSTA then falls but 6-10 days later begins to rise again in parallel with the growth of the SL2 tumour either in the peritoneal cavity or subcutaneously. Following surgical removal of an intradermal SL2 tumour the level of TSTA in the serum falls rapidly. No evidence could be found that a significant proportion of the TSTA in the serum of tumour-bearing mice is completed with antibody. However, in the serum of DBA2 mice which have been hyperimmunized with irradiated SL2 cells there are antibodies which bind 125I-TSTA although syngeneic anti-SL2 sera, unlike alloantisera, do not show complement dependent lysis of SL2 cells.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Egan M. L., Lautenschleger J. T., Coligan J. E., Todd C. W. Radioimmune assay of carcinoembryonic antigen. Immunochemistry. 1972 Mar;9(3):289–299. doi: 10.1016/0019-2791(72)90093-6. [DOI] [PubMed] [Google Scholar]
- Hunter W. M. Radioimmunoassay and saturation analysis. Preparation and assessment of radioactive tracers. Br Med Bull. 1974 Jan;30(1):18–23. doi: 10.1093/oxfordjournals.bmb.a071161. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Miyakawa Y., Tanigaki N., Yagi Y., Pressman D. Determination of human histocompatibility antigens in the peripheral blood by radioimmunoassay. Transplantation. 1972 May;13(5):481–485. doi: 10.1097/00007890-197205000-00006. [DOI] [PubMed] [Google Scholar]
- Thomson D. M., Sellens V., Eccles S., Alexander P. Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers. Br J Cancer. 1973 Nov;28(5):377–388. doi: 10.1038/bjc.1973.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WIGZELL H. QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING CR-51-LABELLED TARGET CELLS. Transplantation. 1965 May;3:423–431. doi: 10.1097/00007890-196505000-00011. [DOI] [PubMed] [Google Scholar]
- Welsh K. I., Sanderson A. R. Properties of histocompatibility (HL-A) determinants. II. Soluble antigen-antibody complexes. Transplantation. 1974 Mar;17(3):290–298. doi: 10.1097/00007890-197403000-00009. [DOI] [PubMed] [Google Scholar]
- Wolf A., Barfoot R. K., Johnson R. A. Xenogeneic recognition of tumour spcific plasma membrane antigens derived from mouse lymphoma cells. Immunology. 1972 Mar;22(3):485–491. [PMC free article] [PubMed] [Google Scholar]
- Wolf A., Steele K. A. Separation of a tumour specific transplantation-type antigen from the ascitic fluid of mice bearing a syngeneic lymphoma. Br J Cancer. 1975 Jun;31(6):684–688. doi: 10.1038/bjc.1975.116. [DOI] [PMC free article] [PubMed] [Google Scholar]